Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention
Metz, DK; Holford, N; Kausman, JY; Walker, A; Cranswick, N; Staatz, CE; Barraclough, KA; Ierino, F
(2019), TRANSPLANTATION, 2012-2030
Examining the Increased Rates of Deceased Donor Kidney Nonutilization in Australia: What Has Changed?
Sypek, MP; Ullah, S; Hughes, PD; Clayton, PA; McDonald, SP
(2019), TRANSPLANTATION, 2582-2590
External validation of the US and UK kidney donor risk indices for deceased donor kidney transplant survival in the Australian and New Zealand population
Clayton, PA; Dansie, K; Sypek, MP; White, S; Chadban, S; Kanellis, J; Hughes, P; Gulyani, A; McDonald, S
(2019), NEPHROLOGY DIALYSIS TRANSPLANTATION, 2127-2131
DOI: 10.1093/ndt/gfz090
Diagnostic Tests for Vascular Calcification
Smith, ER; Hewitson, TD; Holt, SG
(2019), ADVANCES IN CHRONIC KIDNEY DISEASE, 445-463
Improving medication adherence in adult kidney transplantation (IMAKT): A pilot randomised controlled trial
Low, JK; Manias, E; Crawford, K; Walker, R; Mulley, WR; Toussaint, ND; Dooley, M; Kennedy, E; Smith, CL; Nalder, M; Yip, D; Williams, A
(2019), SCIENTIFIC REPORTS
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study
Germain, DP; Nicholls, K; Giugliani, R; Bichet, DG; Hughes, DA; Barisoni, LM; Colvin, RB; Jennette, JC; Skuban, N; Castelli, JP; Benjamin, E; Barth, JA; Viereck, C
(2019), GENETICS IN MEDICINE, 1987-1997
Pre-analytical stability of FGF23 with the contemporary immunoassays
Dirks, NF; Smith, ER; van Schoor, NM; Vervloet, MG; Ackermans, MT; de Jonge, R; Heijboer, AC
(2019), CLINICA CHIMICA ACTA, 104-106
The Fibrosis Across Organs Symposium: A Roadmap for Future Research Priorities
Roman, J; Barnes, TR; Kervitsky, DJ; Cosgrove, GP; Doherty, DE; Tager, AM; Richeldi, L; White, ES; Brenner, DA; Schnapp, LM; Hewitson, TD; Jugdutt, BI; McKinsey, TA; Tosi, JD; Crane, S; Brown, KK
(2019), AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 405-410
Home haemodialysis: how it began, where it went wrong, and what it may yet be
Agar, JWM; Barraclough, KA; Piccoli, GB
(2019), JOURNAL OF NEPHROLOGY, 331-333
Nephrology in the global environment
Agar, JWM; Barraclough, KA; Piccoli, GB
(2019), JOURNAL OF NEPHROLOGY, 163-164
Association of Handgrip Strength and Muscle Mass with Dependency in (Instrumental) Activities of Daily Living in Hospitalized Older Adults -The EMPOWER Study
Meskers, CGM; Reijnierse, EM; Numans, ST; Kruizinga, RC; Pierik, VD; Van Ancum, JM; Slee-Valentijn, M; Scheerman, K; Verlaan, S; Maier, AB
(2019), JOURNAL OF NUTRITION HEALTH & AGING, 232-238
alpha Klotho-FGF23 interactions and their role in kidney disease: a molecular insight
Smith, ER; Holt, SG; Hewitson, TD
(2019), CELLULAR AND MOLECULAR LIFE SCIENCES, 4705-4724
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial
Schiffmann, R; Goker-Alpan, O; Holida, M; Giraldo, P; Barisoni, L; Colvin, RB; Jennette, CJ; Maegawa, G; Boyadjiev, SA; Gonzalez, D; Nicholls, K; Tuffaha, A; Atta, MG; Rup, B; Charney, MR; Paz, A; Szlaifer, M; Alon, S; Brill-Almon, E; Chertkoff, R; Hughes, D
(2019), JOURNAL OF INHERITED METABOLIC DISEASE, 534-544
DOI: 10.1002/jimd.12080
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
Hughes, DA; Nicholls, K; Sunder-Plassmann, G; Jovanovic, A; Feldt-Rasmussen, U; Schiffmann, R; Giugliani, R; Jain, V; Viereck, C; Castelli, JP; Skuban, N; Barth, JA; Bichet, DG
(2019), AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 1069-1073
DOI: 10.1002/ajmg.a.61105
Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients
See, EJ; Hawley, CM; Cho, Y; Toussaint, ND; Agar, JWM; Pascoe, EM; Lim, WH; Francis, RS; Collins, MG; Johnson, DW
(2019), Nephrology, 111-120
DOI: 10.1111/nep.13221
Surveillance and control of asymptomatic carriers of drug-resistant bacteria
Jamrozik, E; Selgelid, MJ
(2019), Bioethics, 766-775
DOI: 10.1111/bioe.12642
Our observations with cold calling: Patient anger and undesirable experiences
Taylor, DM; Kant, JA; Dombagolla, MHK; Lai, FWY; Hendarto, A
(2019), Emerg. Med. Australas., 283-286
Variables associated with completeness of medical record documentation in the emergency department
Lai, FWY; Kant, JA; Dombagolla, MHK; Hendarto, A; Ugoni, A; Taylor, DM
(2019), Emerg. Med. Australas., 632-638
Subfascial endoscopic perforator surgery (SEPS) for treating venous leg ulcers
Lin, ZC; Loveland, PM; Johnston, RV; Bruce, M; Weller, CD
(2019), Cochrane Database Syst Rev.
Open disclosure of adverse events: exploring the implications of service and policy structures on practice
Harrison, R; Walton, M; Smith-Merry, J; Manias, E; Iedeme, R
(2019), RISK MANAG. HEALTHC. POLICY, 5-12
DOI: 10.2147/RMHP.S180359
Diagnostic yield of computed tomography-guided biopsy and aspiration for vertebral osteomyelitis
Ang, MT; Wong, GR; Wong, DR; Clements, W; Joseph, T
(2019), J. Med. Imag. Radiat. Oncol., 589-595
Emergency medicine: A perspective from the medical ward
Au Yeung, V
(2019), Emerg. Med. Australas., 1106-1106
Health professionals and students encounter multi-level barriers to implementing high-value osteoarthritis care: a multi-national study
Briggs, AM; Houlding, E; Hinman, RS; Desmond, LA; Bennell, KL; Darlow, B; Pizzari, T; Leech, M; MacKay, C; Larmer, PJ; Bendrups, A; Greig, AM; Francis-Cracknell, A; Jordan, JE; Slater, H
(2019), Osteoarthritis Cartilage, 788-804
Does continuous subcutaneous infusion of lignocaine relieve intractable pruritus associated with advanced cutaneous T-cell lymphoma? A retrospective case series review
Norris, J; Barker, J; Buelens, O; Spruijt, O
(2019), Palliat. Med., 552-556
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes
Ohkuma, T; Jun, M; Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Zoungas, S; Perkovic, V; Woodward, M
(2019), Clin. J. Am. Soc. Nephrol., 862-872
DOI: 10.2215/CJN.13391118
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial
Ohkuma, T; Jun, M; Rodgers, A; Cooper, ME; Glasziou, P; Hamet, P; Harrap, S; Mancia, G; Marre, M; Neal, B; Perkovic, V; Poulter, N; Williams, B; Zoungas, S; Chalmers, J; Woodward, M
(2019), Hypertension, 84-91
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
Oshima, M; Jun, M; Ohkuma, T; Toyama, T; Wada, T; Cooper, ME; Hadjadj, S; Hamet, P; Harrap, S; Mancia, G; Marre, M; Williams, B; Chalmers, J; Woodward, M; Perkovic, V
(2019), Diabetologia, 1988-1997
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial
Selvin, E; Wang, D; McEvoy, JW; Juraschek, SP; Lazo, M; Hamet, P; Cooper, ME; Marre, M; Williams, B; Harrap, S; Chalmers, J; Woodward, M
(2019), Diabetes Obes. Metab., 2017-2023
DOI: 10.1111/dom.13755
Frontal fibrosing alopecia: Regrowth following cessation of sunscreen on the forehead
Cranwell, WC; Sinclair, R
(2019), Australas. J. Dermatol., 60-61
DOI: 10.1111/ajd.12833
Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial
Rahman, F; McEvoy, JW; Ohkuma, Y; Marre, M; Hamet, P; Harrap, S; Mancia, G; Rodgers, A; Selvin, E; Williams, B; Muntner, P; Chalmers, J; Woodward, M
(2019), Hypertension, 1291-1299